LOTRONEX (Prometheus Laboratories Inc.)


Welcome to the PulseAid listing for the LOTRONEX drug offered from Prometheus Laboratories Inc.. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Prometheus Laboratories Inc.
NON-PROPRIETARY NAME: alosetron hydrochloride
SUBSTANCE NAME: ALOSETRON HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-02-09
END MARKETING DATE: 0000-00-00


LOTRONEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLOTRONEX from Prometheus Laboratories Inc.
LABELER NAME: Prometheus Laboratories Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2009-02-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65483-894_800b0802-c4e6-409f-adbc-a985d1fca2a5
PRODUCT NDC: 65483-894
APPLICATION NUMBER: NDA021107

Other ALOSETRON HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Alosetron Hydrochloride
Amneal Pharmaceuticals LLCAlosetron Hydrochloride
AvKARE, Inc.Alosetron Hydrochloride
Prometheus Laboratories Inc.LOTRONEX
Sebela Pharmaceuticals Inc.LOTRONEX
West-Ward Pharmaceuticals Corp.Alosetron Hydrochloride